- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 459/00 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine16, 18-lactones thereof, e.g. reserpic acid lactone
Patent holdings for IPC class C07D 459/00
Total number of patents in this class: 19
10-year publication summary
0
|
0
|
0
|
3
|
3
|
2
|
2
|
0
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 827 |
2 |
The Procter & Gamble Company | 22043 |
1 |
The Trustees of Columbia University in the City of New York | 3575 |
1 |
Basilea Pharmaceutica AG | 69 |
1 |
Council of Scientific & Industrial Research | 1425 |
1 |
Cytokinetics, Inc. | 277 |
1 |
John Innes Centre | 32 |
1 |
Napo Pharmaceuticals, Inc. | 43 |
1 |
Pawan Kumar Goel | 6 |
1 |
Research Foundation for Mental Hygiene, Inc. | 66 |
1 |
Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences | 2030 |
1 |
Sloan-Kettering Institute for Cancer Research | 520 |
1 |
Universitat Basel | 298 |
1 |
Sichuan Sainthood Biotech Co., Ltd. | 7 |
1 |
Goel, Pawan Kumar | 9 |
1 |
University of Sharjah | 46 |
1 |
Kumar Goel, Pawan | 1 |
1 |
Univeristy of Sharjah | 1 |
1 |
Other owners | 0 |